How significant is the antifibrinolytic effect of lipoprotein(a) for blood clot lysis?

Thromb Res. 2021 Feb:198:210-212. doi: 10.1016/j.thromres.2020.12.014. Epub 2020 Dec 26.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antifibrinolytic Agents* / therapeutic use
  • Fibrinolysis
  • Humans
  • Lipoprotein(a) / pharmacology
  • Thrombosis*
  • Tissue Plasminogen Activator / pharmacology

Substances

  • Antifibrinolytic Agents
  • Lipoprotein(a)
  • Tissue Plasminogen Activator